Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 442.30M | 388.80M | 368.90M | 309.00M | 90.60M | 311.60M |
Gross Profit | 64.40M | 181.50M | 172.80M | 140.90M | -14.60M | 147.10M |
EBITDA | 75.30M | 63.70M | 76.90M | 82.60M | -2.90M | 70.80M |
Net Income | 13.70M | 11.10M | 29.70M | 34.40M | -38.30M | 19.30M |
Balance Sheet | ||||||
Total Assets | 989.60M | 1.35B | 1.05B | 1.06B | 997.50M | 989.60M |
Cash, Cash Equivalents and Short-Term Investments | 1.10M | 16.90M | 10.70M | 34.00M | 4.70M | 1.10M |
Total Debt | 281.50M | 376.50M | 175.90M | 207.80M | 253.40M | 281.50M |
Total Liabilities | 398.80M | 578.00M | 329.70M | 362.20M | 352.10M | 398.80M |
Stockholders Equity | 590.80M | 771.60M | 724.20M | 699.70M | 645.40M | 590.80M |
Cash Flow | ||||||
Free Cash Flow | 28.80M | 24.90M | 42.70M | 65.00M | -42.10M | 26.10M |
Operating Cash Flow | 74.80M | 73.40M | 82.90M | 101.90M | -23.00M | 59.00M |
Investing Cash Flow | -175.80M | -199.60M | -52.30M | -14.10M | -18.70M | -67.20M |
Financing Cash Flow | 100.30M | 132.40M | -53.90M | -58.50M | 45.30M | 800.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £1.68B | 10.02 | 6.90% | ― | 1.95% | 275.56% | |
74 Outperform | £318.17M | 12.26 | 6.45% | 4.24% | 2.22% | 98.79% | |
73 Outperform | £265.71M | 0.06 | 10.69% | ― | 0.50% | ― | |
67 Neutral | £42.38B | 36.95 | 21.77% | 1.33% | 7.67% | -15.09% | |
67 Neutral | £831.81M | 14.87 | 16.38% | 0.38% | 3.70% | 57.10% | |
66 Neutral | £1.86B | 11.27 | 6.18% | 3.11% | 0.61% | -17.57% | |
60 Neutral | £508.00M | 39.04 | 1.27% | 3.74% | 16.73% | -55.22% |